Insulet Corp. (PODD): Price and Financial Metrics

Insulet Corp. (PODD): $171.68

5.82 (+3.51%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

B

PODD Price/Volume Stats

Current price $171.68 52-week high $335.91
Prev. close $165.86 52-week low $125.82
Day low $164.08 Volume 840,200
Day high $173.76 Avg. volume 931,053
50-day MA $188.65 Dividend yield N/A
200-day MA $204.79 Market Cap 12.00B

PODD Stock Price Chart Interactive Chart >

PODD POWR Grades

  • PODD scores best on the Growth dimension, with a Growth rank ahead of 98.31% of US stocks.
  • The strongest trend for PODD is in Stability, which has been heading down over the past 26 weeks.
  • PODD's current lowest rank is in the Momentum metric (where it is better than 7.41% of US stocks).

PODD Stock Summary

  • PODD's current price/earnings ratio is 113.27, which is higher than 94.68% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for PODD is currently 89.9, higher than 96.79% of US stocks with positive operating cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, INSULET CORP is reporting a growth rate of 145.83%; that's higher than 92.43% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to INSULET CORP are CLPS, ESMT, NABL, PAY, and MASI.
  • PODD's SEC filings can be seen here. And to visit INSULET CORP's official web site, go to www.insulet.com.

PODD Valuation Summary

  • PODD's price/earnings ratio is 126.3; this is 333.28% higher than that of the median Healthcare stock.
  • PODD's price/sales ratio has moved down 97.6 over the prior 202 months.

Below are key valuation metrics over time for PODD.

Stock Date P/S P/B P/E EV/EBIT
PODD 2023-12-29 9.7 24.9 126.3 107.7
PODD 2023-12-28 9.8 25.2 127.7 108.9
PODD 2023-12-27 9.9 25.5 128.8 109.8
PODD 2023-12-26 9.9 25.4 128.4 109.5
PODD 2023-12-22 9.7 24.8 125.8 107.3
PODD 2023-12-21 9.8 25.2 127.4 108.6

PODD Growth Metrics

    The year over year net cashflow from operations growth rate now stands at -188.95%.
  • Its 5 year revenue growth rate is now at 100.43%.
  • Its 2 year net cashflow from operations growth rate is now at -152.81%.
PODD's revenue has moved up $268,100,000 over the prior 15 months.

The table below shows PODD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 1,305.3 119 4.6
2022-09-30 1,243.3 42.8 16.8
2022-06-30 1,178.1 -39.7 34.6
2022-03-31 1,141.9 -46.7 44.6
2021-12-31 1,098.8 -68.1 16.8
2021-09-30 1,037.2 -43.6 -29.5

PODD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PODD has a Quality Grade of C, ranking ahead of 61.86% of graded US stocks.
  • PODD's asset turnover comes in at 0.542 -- ranking 84th of 186 Medical Equipment stocks.
  • UFPT, NEPH, and NSPR are the stocks whose asset turnover ratios are most correlated with PODD.

The table below shows PODD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.542 0.666 0.011
2021-03-31 0.544 0.650 0.036
2020-12-31 0.573 0.644 0.034
2020-09-30 0.621 0.640 0.049
2020-06-30 0.642 0.638 0.040
2020-03-31 0.691 0.644 0.029

PODD Price Target

For more insight on analysts targets of PODD, see our PODD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $290.41 Average Broker Recommendation 1.6 (Moderate Buy)

Insulet Corp. (PODD) Company Bio


A medical device company developing and marketing insulin infusion system. (Source:Wiki)


PODD Latest News Stream


Event/Time News Detail
Loading, please wait...

PODD Latest Social Stream


Loading social stream, please wait...

View Full PODD Social Stream

Latest PODD News From Around the Web

Below are the latest news stories about INSULET CORP that investors may wish to consider to help them evaluate PODD as an investment opportunity.

Here's Why You Should Invest in Insulet (PODD) Stock for Now

Investors are optimistic about Insulet (PODD), led by the strong adoption of Omnipod 5 and its strong solvency position.

Yahoo | December 28, 2023

Bull of the Day: Insulet (PODD)

A big earnings beat at the perfect time has this stock up over 50% in short order.

Yahoo | December 28, 2023

Top Stock Picks for Week of December 25, 2023

An Interesting Bet for Trend Investors and a Leading Medical Products Stock for Your Review

Yahoo | December 27, 2023

Here's How Much a $1000 Investment in Insulet Made 10 Years Ago Would Be Worth Today

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Yahoo | December 27, 2023

3 Medical-Device Stocks Could Click in 2024

Baird is bullish on Boston Scientific, Insulet, and DexCom, stocks set to benefit as those companies ramp up sales.

Yahoo | December 26, 2023

Read More 'PODD' Stories Here

PODD Price Returns

1-mo -10.12%
3-mo -17.45%
6-mo 7.35%
1-year -46.06%
3-year -34.23%
5-year 68.53%
YTD -20.88%
2023 -26.30%
2022 10.64%
2021 4.08%
2020 49.32%
2019 115.83%

Continue Researching PODD

Here are a few links from around the web to help you further your research on Insulet Corp's stock as an investment opportunity:

Insulet Corp (PODD) Stock Price | Nasdaq
Insulet Corp (PODD) Stock Quote, History and News - Yahoo Finance
Insulet Corp (PODD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!